human | Q5 |
P496 | ORCID iD | 0000-0001-8353-6473 |
P735 | given name | ??? | Q13138335 |
??? | Q13138335 | ||
P106 | occupation | researcher | Q1650915 |
Q37398801 | Analytical strategies for phosphoproteomics |
Q37400668 | Enrichment and separation of mono- and multiply phosphorylated peptides using sequential elution from IMAC prior to mass spectrometric analysis |
Q31164900 | Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. |
Q57279159 | Highly selective enrichment of phosphorylated peptides using titanium dioxide |
Q35846359 | Phosphopeptide Enrichment by Immobilized Metal Affinity Chromatography |
Q30992797 | Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients |
Q33307225 | SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides |
Q50910794 | Sequential Elution from IMAC (SIMAC): An Efficient Method for Enrichment and Separation of Mono- and Multi-phosphorylated Peptides. |
Q33600052 | Strategies for quantitation of phosphoproteomic data |
Q37616097 | Technologies for plasma membrane proteomics. |
Q35846363 | The Use of Titanium Dioxide for Selective Enrichment of Phosphorylated Peptides |
Q37400666 | The use of titanium dioxide micro-columns to selectively isolate phosphopeptides from proteolytic digests |
Q39968401 | TiO(2)-based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment |
Q57279144 | Undesirable Charge-Enhancement of Isobaric Tagged Phosphopeptides Leads to Reduced Identification Efficiency |
Q89794565 | Why and how to investigate the role of protein phosphorylation in ZIP and ZnT zinc transporter activity and regulation |
Q55345812 | XK-related protein 5 (XKR5) is a novel negative regulator of KIT/D816V-mediated transformation. |
Search more.